Loading market dashboard
Abbott Laboratories
ABTHealthcareNYSEUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Abbott Laboratories · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $68.25B | $66.09B - $68.71B | $18.26B | $8.357 | 9 |
| Dec 2029 | $63.43B | $61.43B - $63.87B | $16.97B | $7.542 | 11 |
| Dec 2028 | $58.93B | $58.81B - $59.04B | $15.77B | $6.746 | 18 |
| Dec 2027 | $54.94B | $54.15B - $55.36B | $14.70B | $6.055 | 19 |
| Dec 2026 | $50.40B | $50.35B - $50.49B | $13.49B | $5.474 | 19 |
| Dec 2025 | $44.67B | $44.25B - $44.76B | $11.95B | $5.152 | 18 |
| Dec 2024 | $42.00B | $41.87B - $42.08B | $11.24B | $4.675 | 16 |
| Dec 2023 | $40.73B | $39.44B - $41.00B | $10.90B | $3.181 | 15 |
| Dec 2022 | $43.22B | $42.79B - $44.04B | $10.75B | $5.232 | 6 |
| Dec 2021 | $42.32B | $41.90B - $43.12B | $10.02B | $5.099 | 7 |
| Dec 2020 | $33.85B | $33.51B - $34.49B | $7.71B | $3.55 | 11 |
| Dec 2019 | $31.86B | $31.54B - $32.46B | $7.66B | $3.243 | 6 |